Mutual funds have become large shareholders in most public U.S. firms. The resulting overlaps in ownership are boosting corporate profits but harming consumers, according to a new study co-authored by Florian Ederer of Yale SOM.
Instead, argues Yale SOM’s Fiona Scott Morton, the government should exercise its regulatory powers to promote competition.
A recent lawsuit alleged that a billionaire investor bought the rights to a new drug just to eliminate a potential competitor. We asked Yale SOM's Florian Ederer to explain why a "catch-and-kill" merger can be damaging and what to do about the phenomenon.
Prof. Scott Morton called a private healthcare system without competitive pressure “the worst of both worlds” in terms of costs.
U.S. antitrust laws, Yale SOM’s Fiona Scott Morton says, were written when new technology meant “typewriters and buggy whips and bicycles.” She assembled a group of economists and legal scholars to examine areas in which enforcement is out of sync with a changing economy.
A study co-authored by Yale SOM researchers Florian Ederer and Song Ma suggests that “killer acquisitions” by pharmaceutical companies are potentially limiting the number of new treatments available.
Professor Fiona Scott Morton, the former chief economist in the Antitrust Division of the U.S. Department of Justice, on the state of global competition law.
Can laws created to rein in the monopolies of the industrial age still work in the information age? After spending a year as the top antitrust economist at the U.S. Department of Justice, Professor Fiona Scott Morton describes the state of antitrust regulation today.